Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis

Medicine

Volumn 83, Issue 6, 2004, Pages 342-347

  Gonzalez Gay, Miguel A ^a   Piñeiro, Angela ^a   Gomez Gigirey, Adriana ^a   Garcia Porrua, Carlos ^a   Pego Reigosa, Robustiano ^a   Dierssen Sotos, Trinidad ^b   Llorca, Javier ^b  

^a HOSPITAL XERAL CALDE   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; TRIFLUSAL;

AGED; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CLAUDICATION; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; GIANT CELL ARTERITIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING HABIT; TRANSITIONAL BLINDNESS; VISUAL IMPAIRMENT;

AGED; ARM; ARTERIOSCLEROSIS; BLINDNESS; CEREBROVASCULAR ACCIDENT; FEMALE; GLUCOCORTICOIDS; HUMANS; ISCHEMIA; JAW DISEASES; LEG; MALE; PREDNISONE; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; TEMPORAL ARTERITIS;

EID: 9144240151     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.md.0000145369.25558.b5     Document Type: Article

References (18)

1. Duhaut P, Pinede L, Demolombe-Rague S, Loire R, Seydoux D, Ninet J, Pasquier J. Giant cell arteritis and cardiovascular risk factors. A multicenter, prospective case-control study. Arthritis Rheum. 1998;41: 1960-1965.
2. Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. Medicine (Baltimore). 1999;78:292-308.
3. Gonzalez-Gay MA, Garcia-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am. 2001;27:729-749.
4. Gonzalez-Gay MA, Blanco R, Abraira V, Garcia-Porrua C, Ibanez D, Garcia-Pais MJ, Rigueiro MT, Sanchez-Andrade A, Guerrero J, Casariego E. Giant cell arteritis in Lugo (Spain) is associated with low longterm mortality. J Rheumatol. 1997;24:2171-2176.
5. Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, Llorca J. Influence of age, sex, and place of residence on clinical expression of giant cell arteritis in northwest Spain. J Rheumatol. 2003;30: 1548-1551.
6. Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, Llorca J. Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population. Arthritis Rheum. 2004;51:652-655.
7. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Hajeer AH, Branas F, Dababneh A, Gonzalez-Louzao C, Rodriguez-Gil E, Rodriguez-Ledo P, Ollier WE. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore). 2000;79: 283-292.
8. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M, Dababneh A, Hajeer A, Ollier WER. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a ten year-study. J Rheumatol. 1999;26:1326-1332.
9. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW, Masi AT, McShane DJ, Mills JA, Wallace SL, Zvaifler NJ. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122-1128.
10. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978;88:162-167.
11. Lie JT and the Members and Consultants of the American College of Rheumatology Subcommittee on Classification of Vasculitis. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum. 1990;33:1074-1087.
12. Machado EBV, Gabriel SE, Beard CM, Michet CJ, O'Fallon WM, Ballard DJ. A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease? Int J Epidemiol. 1989;18:836-841.
13. Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med. 1996;100:193-196.
14. Monte R, Gonzalez-Gay MA, Garcia-Porrua C, Lopez-Alvarez MJ, Pulpeiro JR. Successful response to angioplasty in a patient with upper limb ischaemia secondary to giant cell arteritis. Br J Rheumatol. 1998; 37:344.
15. O'Brien JP. A new risk factor and other actinic radiation in giant cell arteritis and atherosclerosis. Int J Dermatol. 1987;26:345-348.
16. O'Brien JP. Vascular accident after actinic (solar) exposure: an aspect of the temporal arteritis/polymyalgia rheumatica syndrome. Int J Dermatol. 1987;26:366-370.
17. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347:261-271.
18. Uddhammar A, Eriksson AL, Nystrom L, Stenling R, Rantapaa-Dahlqvist S. Increased mortality due to cardiovascular disease in giant cell arteritis in northern Sweden. J Rheumatol. 2002;29:737-742.